Skip to main content

Advertisement

SpringerLink
Log in

Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Hair loss is a common dermatosis symptom and side-effect in cancer chemotherapeutics. Imiquimod application at mid and late telogen activated the hair follicle stem cells leading to premature hair cycle entry. Based on quinoline structure, a newly synthesized compound 6b displayed proliferation activity in vitro and in vivo through branch chain replacement and triazole ring cyclization. Toll-like receptors (TLRs) are also critical mediators of the immune system, and their activation is linked to various diseases. The present study aimed to expand new agonists within co-crystallization of TLR7 (PDB code: 5GMH); however, biological assays of NF-κB activity and NO-inhibition indicated that five selected compounds were TLR7 antagonists. Molecular docking indicated the binding mode differences: antagonists binding TLR7 in a different direction and interacting with adjacent TLR7 with difficulty in forming dimers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Nalluri R, Harries M (2016) Alopecia in general medicine. Clin Med 16(1):74–78

    Article  Google Scholar 

  2. Chen C, Chang Y, Liu H, Chen Y (2018) Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study. Cancer Med 7:2153–2159

    Article  Google Scholar 

  3. Seo H, Han S, Kim J (2018) Cancer risks among patients with alopecia areata: a population-based case-control study in Korea. J Am Acad Dermatol 78:209–211

    Article  Google Scholar 

  4. Roe H (2011) Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs 20:S4–S11

    Article  Google Scholar 

  5. Jayde V, Boughton M, Blomfield P (2013) The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer. Eur J Cancer Care (Engl) 22:503–512

    Article  CAS  Google Scholar 

  6. Wang J, Lu Z, Au LS (2006) Protection against chemotherapy-induced alopecia. Pharm Res (Dordrecht) 23(11):2505–2514

    Article  CAS  Google Scholar 

  7. Trüeb RM (2009) Chemotherapy-induced alopecia. Semin Cutan Med Surg 28(1):11–14

    Article  Google Scholar 

  8. Panteleyev A (2018) Functional anatomy of the hair follicle: the secondary hair germ. Exp Dermatol 27:701–720

    Article  CAS  Google Scholar 

  9. Chen R, Miao Y, Hu Z (2019) Dynamic nestin expression during hair follicle maturation and the normal hair cycle. Mol Med Rep 19(1):549–554

    CAS  PubMed  Google Scholar 

  10. Ralf P, Haslam Iain S, Sharov Andrey A et al (2013) Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14:e50–e59

    Article  Google Scholar 

  11. Amberg N, Holcmann M, Stulnig G, Sibilia M (2016) Effects of Imiquimod on hair follicle stem cells and hair cycle progression. J Invest Dermatol 136(11):2140–2149

    Article  CAS  Google Scholar 

  12. Letada PR, Sparling JD, Norwood C (2007) Imiquimod in the treatment of alopecia universalis. Cutis 79(2):138–140

    PubMed  Google Scholar 

  13. Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341(7):491–497

    Article  CAS  Google Scholar 

  14. Kontogiorgis CA, Hadjipavloulitina DJ (2017) Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem 48(20):6400–6408

    Article  Google Scholar 

  15. Zheng Y, Hsieh J-C, Escandon J, Cotsarelis G (2016) Isolation of mouse hair follicle bulge stem cells and their functional analysis in a reconstitution assay. Methods Mol Biol Chapter 8. 1453:57-69

  16. Ma DR, Yang EN, Lee ST (2004) A review: the location, molecular characterisation and multipotency of hair follicle epidermal stem cells. Ann. Acad. Med. Singap 33:784–788

    CAS  PubMed  Google Scholar 

  17. Meihua G, Pan Z, Chunyang L et al (2018) Protective mechanism of adipose-derived stem cells in Remodelling of the skin stem cell niche during Photoaging. Cell Physiol Biochem 51:2456–2471

    Article  Google Scholar 

  18. Sasaki S, Baba T, Muranaka H, Tanabe Y, Takahashi C, Matsugo S, Mukaida N (2018) Involvement of prokineticin 2-expressing neutrophil infiltration in 5-fluorouracil-induced aggravation of breast cancer metastasis to lung. Mol Cancer Ther 17:1515–1525

    Article  CAS  Google Scholar 

  19. Wang D, Bhagat L, Yu D, Zhu FG, Tang JX, Kandimalla ER, Agrawal S (2009) Oligodeoxyribonucleotide-based antagonists for toll-like receptors 7 and 9. J Med Chem 52(2):551–558

    Article  CAS  Google Scholar 

  20. Drake M, Scott G, Proskocil B et al (2013) Toll-like receptor 7 rapidly relaxes human airways. Am J Respir Crit Care Med 188(6):664–672

    Article  CAS  Google Scholar 

  21. Young A, Arif A (2016) The use of scalp cooling for chemotherapy-induced hair loss. Br J Nurs 25:S22–S27

    Article  Google Scholar 

  22. Katikaneni R, Ponnapakkam T, Matsushita O, Sakon J, Gensure R (2014) Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. Anti-Cancer Drugs 25(1):30–38

    Article  CAS  Google Scholar 

  23. Belen R-G, Margit J, Jamie F et al (2018) Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol 57:1417–1424

    Article  Google Scholar 

  24. Rubtsova K, Marrack P, Rubtsov AV (2015) TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity. Cell Immunol 294(2):80–83

    Article  CAS  Google Scholar 

  25. Swindell William R, Michaels Kellie A, Sutter Andrew J et al (2017) Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis. Genome Med 9:24

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The key structures have applied Chinese patent. (CN201711279295, CN108003153A).

We thank Zhejiang Ruyao Biotech Co.,LTD for technologic support.

Funding

The work was supported by National Natural Science Foundation of China (No. 81603218).

Author information

Authors and Affiliations

  1. Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Panjiayuan Nanli 17, Chaoyang Qu, Beijing, 100021, China

    Jincheng Yang, Shuya Qi & Weihua Wang

  2. State Key Laboratory of Molecular Oncology/Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China

    Kun Chen

  3. Clinical Stem Cell Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China

    Bin Wang & Liudi Wang

Authors
  1. Jincheng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liudi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuya Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weihua Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jincheng Yang.

Ethics declarations

Conflict of interest

Author Jincheng Yang declares that he has no conflict of interest. Author Kun Chen declares that she has no conflict of interest. Author Bin Wang declares that he has no conflict of interest. Author Liudi Wang declares that she has no conflict of interest. Author Shuya Qi declares that she has no conflict of interest. Author Weihua Wang declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors. Animal experiments were approved by the Institutional Animal Care and Use Committee at National Cancer Center, Chinese Academy of Medical Sciences. (NCC2016A050, 9 March 2016) All applicable international, national, and institutional guidelines for the care and use of animals were followed.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, J., Chen, K., Wang, B. et al. Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia. Invest New Drugs 38, 79–91 (2020). https://doi.org/10.1007/s10637-019-00793-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-019-00793-5

Keywords

Search

Navigation